Consuming caffeinated energy drinks can significantly increase systolic and diastolic blood pressure (BP).
Examining vitamin D from a scientific standpoint finds that many supposed benefits are not validated.
Valeant announced that PreserVision AREDS 2 Formula + Multivitamin is now available for patients with moderate to advanced age-related macular degeneration.
Shire and Kamada announced that the Food and Drug Administration (FDA) has approved Glassia (alpha-1 proteinase inhibitor [human]) as the first treatment for adults with emphysema due to severe alpha-1 antitrypsin (AAT) deficiency that can be self-infused at home after appropriate training.
Sobi announced that the FDA has approved a new 20mg strength of Orfadin (nitisinone) capsules for the treatment of hereditary tyrosinemia type-1 (HT-1), a rare genetic disease in infants and children.
The device - which is inserted through a small incision in the abdomen - was associated with a ~12.1% total body weight loss in a clinical trial.
Janssen announced findings of a Phase 2 proof-of-concept clinical trial demonstrating that combination therapy of canagliflozin and phentermine was effective for weight loss in overweight or obese non-diabetic adult patients. Data were presented as a late-breaking poster presentation at the 76th Annual Scientific Sessions of the American Diabetes Association (ADA).
The Food and Drug Administration (FDA) announced that it has taken enforcement action on 4,402 websites illegally selling potentially dangerous, unapproved prescription drugs to U.S. consumers.
Pharmavite announced the recall of certain lots of Nature Made products due to possible Salmonella or Staphylococcus aureus contamination.
Adding vitamin D may lessen the risk of developing new-onset diabetes in patients taking atypical antipsychotics, according to a study published in Scientific Reports.
The FDA issued both short- and long-term targets to gradually reduce sodium levels in processed and prepared foods.
Vertex has announced that the Food and Drug Administration (FDA) has accepted for filing and granted Priority Review to their supplemental New Drug Application (sNDA) for Orkambi (lumacaftor/ivacaftor).
The Food and Drug Administration today announced new updates to the nutritional facts label to appear on most packaged foods sold across the U.S.
A new commentary published in the Journal of Pediatrics calls for healthcare providers to play a greater role in educating non-celiac disease patients on the consequences of converting to a gluten-free diet (GFD).
Previous studies have suggested that nutritional supplementation may lower aggressive behavior in children.
SOS Telecom is voluntarily recalling four of their products that were marketed as dietary supplements for male sexual enhancement. The product names are, Tiger-X, Ninja-X, Ginseng Power-X, and Super Samurai-X.
Researchers from Johns Hopkins Bloomberg School of Public Health reported that too much folate in a new mother's body may increase a child's risk of developing an autism spectrum disorder. Findings from the study will be presented at the 2016 International Meeting for Autism Research.
The FDA has granted Orphan Drug designation to ALLN-177 (oxalate decarboxylase; Allena) for the treatment of pediatric hyperoxaluria.
Consuming multiple cups of coffee a day is likely to be safe for the kidneys in the general population, and is associated with an increase in estimated glomerular filtration rate (eGFR), according to findings of a study from the Netherlands.
In a commentary published in EMBO reports, study authors present data showing that herbals containing Aristolochia species can cause aristolochic acid nephropathy (AAN).
For children with mild gastroenteritis and minimal dehydration, initiating diluted apple juice followed by their preferred fluids led to fewer treatment failures vs. electrolyte maintenance solution, according to findings from a study published in JAMA.
The Food and Drug Administration (FDA) has approved Orfadin (nitisinone; Sobi) Oral Suspension for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
Findings from a new study published in The American Journal of Psychiatry suggest that some nutritional supplements can enhance the efficacy of antidepressants for patients with depression.
The FDA has granted Orphan Drug designation to Mul-1867 (TGV-Inhalonix) for the treatment of antibiotic-resistant bacterial lung infections in patients with cystic fibrosis.
Super Herbs announced a voluntary recall of its Super Herbs light green and dark green capsules after FDA laboratory testing found them to contain sibutramine, desmethylsibutramine, and/or phenolphthalein.
A Cochrane review found no high quality evidence to support the efficacy of any dietary supplement for dysmenorrhea.
Metformin and pioglitazone showed anti-inflammatory effects in patients with multiple sclerosis and metabolic syndrome, according to a new study published in JAMA Neurology.
Lantheus announced new data from a sub-analysis of its Phase 3 study on flurpiridaz F 18 for myocardial perfusion imaging (MPI) in obese patients.
Few patients seem to use weight loss medications to treat obesity despite guideline recommendations and the availability of FDA-approved drugs, suggests a new study presented at ENDO 2016.
Invisiblu International announced a voluntary recall of one lot of Continuum Labs LGD-Xtreme 3mg capsules.
Young children who take antibiotics may disrupt their gut microbes and be more likely to develop adolescent prediabetes.
In overweight or obese patients with prediabetes, the addition of liraglutide (Saxenda; Novo Nordisk) 3mg to diet and exercise may result in major health improvements, according to a study presented at ENDO 2016.
Polycystic ovary syndrome (PCOS) and excess weight have been independently linked with the onset of asthma, according to findings in a new study to be presented at the annual Endocrine Society meeting.
Cambrooke Therapeutics announced the launch of KetoVie Peptide, the first ketogenic hydrolyzed whey-based (peptides) formula for patients on a ketogenic diet with milk protein sensitivities and/or impaired digestive function.
Abbott announced the launch of Ensure Enlive, a complete and balanced nutrition drink to help rebuild lost muscle and regain strength and energy.
Aloe vera may hold some benefit in improving glycemic control in prediabetes and type 2 diabetes, according to a a new study published in the Journal of Clinical Pharmacy and Therapeutics.
A study published in Endocrinology showed that exposure to the chemical bisphenol S can induce fat cell formation.
NOW Health Group announced a voluntary recall of 6 dietary supplements that were mislabeled due to a printing error by the label supplier.
BioMarin announced positive preliminary results from the pivotal Phase 3 PRISM-2 study of pegvaliase for the reduction of blood phenylalanine (Phe) in patients with phenylketonuria (PKU).
Hospira announced a voluntary recall of one lot of Sodium Bicarbonate Injection 8.4%, USP, due to particulate presence within a single-dose glass fliptop vial from a confirmed complaint.
A new study in JAMA Internal Medicine indicated that since 2005, the risk of major drug interaction in older adults has increased in those taking multiple prescriptions and dietary supplements concurrently.
New research published in Translational Psychiatry supports the link between omega-3 supplementation and a reduction in major depressive disorder (MDD).
In women who use oral contraceptives, obesity is a strong risk factor for cerebral venous thrombosis.
Long-term use of metformin may increase the risk of vitamin B12 deficiency and possibly other complications (anemia, neuropathy).
Results from an interim analysis published in JAMA showed that the cardiovascular safety of the obesity treatment, naltrexone/bupropion "remains uncertain."
A molecular circuit has been identified that controls beige adipocyte biogenesis, according to research published online in Diabetes.
Strawberry consumption may help reduce postprandial insulin concentrations in obese individuals with insulin resistance (IR), a new study has found.
A daily dose of beetroot juice was found to significantly improve exercise endurance and blood pressure in elderly patients.
Eating more foods containing vitamin D— but not supplemental vitamin D— during pregnancy was related to a lower risk of development in allergies in children, a study led by Mount Sinai researchers showed.
The high-fat, low-carb ketogenic diet (KD) may provide positive effects for child epilepsy patients.
A diet containing unsaturated fats—as found in olive oil and walnuts—showed similar weight loss effects as a lower fat, higher carbohydrate diet, according to a study published in the Journal of the American heart Association.
The Food and Drug Administration (FDA) has issued a Complete Response Letter for the supplemental New Drug Application (sNDA) of Kalydeco (ivacaftor; Vertex) in patients with cystic fibrosis (CF) ≥2 years old who have one of 23 residual function mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
The five most common reasons for Food and Drug Administration (FDA)-issued recalls were contamination, mislabeling, adverse reaction, defective product, and incorrect potency, a new study has found.
The Food and Drug Administration (FDA) has granted Fast Track designation to Ryanodex (dantrolene sodium; Eagle) injectable suspension for the treatment of exertional heat stroke (EHS).
The Food and Drug Administration (FDA) has warned against the use of Bentonite Me Baby by Alikay Naturals due to a potential lead poisoning risk.
Baxter announced a voluntary recall of 4 lots of intravenous (IV) solutions due to the potential for leaking containers and particulate matter.
Two new trials have found no significant statistical reduction in cases of persistent wheezing and asthma where the mother had taken additional vitamin D supplements.
In a clinical study of 652 malnourished adults aged 65 years or older, a specialized oral nutrition supplement was linked to a 50% lower death rate 90 days after hospitalization.
The Food and Drug Administration (FDA) has granted setmelanotide (Rhythm) Breakthrough Therapy designation for the treatment of pro-opiomelanocortin (POMC) deficiency obesity and Orphan Drug designation for the treatment of Prader-Willi Syndrome (PWS).
U.S. News & World Report released the 2016 Best Diets featuring ranking and information on diet plans to hep those who diet achieve healthier lifestyles.
Baxter announced a voluntary recall of 2 lots of 0.9% Sodium Chloride Injection, 250mL Viaflex Plastic Container and 70% Dextrose Injection, 2000mL, due to potential presence of particulate matter.
Vitamin D supplements provide no benefit on low extremity function and raise the risk of falling for patients 70 or older, according to a clinical trial published in JAMA Internal Medicine.
New research published in Autoimmunity Reviews showed that eating processed foods weaken the intestine's resistance to bacteria, toxins, and other hostile nutritional and non-nutritional elements, which increases the chances of developing autoimmune diseases.
Researchers from Johns Hopkins University reported that a high dose of vitamin D3 is safe for people with multiple sclerosis (MS) and may help regulate the body's hyperactive immune response.
BeeXtreme LLC announced a recall of all lots of La' Trim Plus, Jenesis, and Oasis products from the market.
A recent study has shown that fibroblast growth factor 21 (FGF21), a liver-generated hormone, suppresses the consumption of simple sugars.
A Working Group created by the Trans-National Institutes of Health (NIH) Committee on Genes, Behavior and Response to Weight Loss Interventions aimed to better understand how genes affect weight both biologically and behaviorally.
SmartLipo365 announced a voluntary recall of all lots of Smart Lipo 800mg, 900mg, and 950mg capsules after an analysis found undeclared sibutramine, desmethylsibutramine, and phenolphthalein.
A study appearing in the Journal of the American Society of Nephrology concluded vitamin D supplements did not help treat anemia in patients on hemodialysis.
Coffee can increase athletic endurance by an average of 24%, according to a new study published in the International Journal of Sport Nutrition and Exercise Metabolism.
Neothetics announced results from its AbCONTOUR1 and AbCONTOUR2 Phase 3 trials which evaluated the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat.
Individuals who participate in higher impact activities may require higher vitamin D levels to reduce their risk of stress fractures, a new study in The Journal of Foot & Ankle Surgery reported.
Sleeping less than seven hours a night contributes to more secondary eating and drinking, thus increasing obesity risk, according to a new study by researchers at the University of Alabama.
Alcresta has received de novo approval from the FDA to market Relizorb (immobilized lipase), a first-of-its kind digestive enzyme cartridge that breaks down fats in enteral tube feeding formula to mimic normal pancreatic function.
Apigenin, a flavonoid found in some spices and herbs, may improve neuron formation and strengthen connections between brain cells, researchers from D'Or Institute for Research and Education reported.
Lucy's Weight Loss System announced a voluntary recall of all lots of Pink Bikini White Powder Capsules after it was found to contain a non-steroidal anti-inflammatory drug (NSAID).
Alexion announced that the Food and Drug Administration (FDA) has approved Kanuma (sebelipase alfa) for the treatment of patients with lysosomal acid lipase deficiency (LAL-D).
New cards detailing baseline data on physical inactivity for 131 countries have been released by The Global Observatory for Physical Activity (GoPA!)
Weight loss supplement Lipo Escultura was recalled and further manufacturing discontinued after it was found to contain sibutramine and diclofenac.
The FDA has accepted for filing the New Drug Application (NDA) for extended-release lorcaserin (Eisai and Arena) as once daily dosing option for chronic weight management.
Patients with bipolar disorder had lower levels of certain omega-3 fatty acids that cross the blood-brain barrier than those without bipolar disorder, a study published in Bipolar Disorders reported.
Low vitamin D levels may hinder the efficacy of HIV treatment in adults, researchers from the University of Georgia reported.
A new study reports that the "portfolio diet", developed to reduce cholesterol, may help lower blood pressure (BP) as well.
Recent research suggests that there is not enough evidence to support the use of omega-3 fatty acid supplements for the treatment of major depressive disorder (MDD).
Results from one of the largest studies ever conducted to understand obesity treatment coverage show that 3 out of 4 consumers report they are not covered for necessary, evidence-based obesity treatment services. Findings from the study were presented at ObesityWeek 2015.
New clinical trial data presented at ObesityWeek 2015 showed that treatment with Saxenda (liraglutide) in combination with a reduced-calorie diet and increased physical activity led to significant and sustained weight loss over 3 years vs. placebo.
One night of sleep deprivation and 6 months on a high-fat diet could both impair insulin sensitivity to a similar degree, new research presented at ObesityWeek 2015 has shown.
New results from a pair of studies suggest that lean individuals and those with obesity experience different brain responses to written food words, and that both stress and genetics could influence excess eating.
Researchers report an increase in overall prescription drug use among adults in the United States between 1999-2012. Findings from the study are published in JAMA.
Vitamin D supplements may improve exercise performance and reduce the risk of heart disease, according to findings of a preliminary study presented at the Society for Endocrinology annual conference.
Alexion announced that the Food and Drug Administration (FDA) has approved Strensiq (asfotase alfa) for the treatment of patients with perinatal-, infantile-, and juvenile-onset hypophosphatasia (HPP). Strensiq is the first treatment approved for the treatment of HPP, a genetic and chronic ultra-rare metabolic disorder.
Lab analysis has confirmed that each of these products contains an active hidden ingredient.
Despite recommendations against the use of creatine in children under the age of 18, a study to be presented at the American Academy of Pediatrics (AAP) National Conference & Exhibition found that more than two-thirds of health food store clerks recommended this sports performance supplement to someone posing as a 15-year-old male.
Children who take antibiotics throughout their childhood may have a significantly greater risk of weight gain in adolescence compared to those who take no antibiotics, particularly with a specific antibiotic class of drugs, according to a study in the International Journal of Obesity.
The Centers for Disease Control and Prevention (CDC) has launched an updated Foodborne Outbreak Online Database Tool (FOOD Tool) to assist users in searching over nearly 20 years of outbreak data.
The Food and Drug Administration (FDA) has issued a safety alert to consumers regarding imported products marketed as dietary supplements and non-prescription drug products, often sold at ethnic or international stores, flea markets, swap meets, or online.
Although greater consumption of dietary calcium may lower the risk of kidney stone recurrence, research presented at the American Society of Nephrology's (ASN) Kidney Week 2015 in San Diego, suggests that calcium supplementation could actually increase this risk.
The Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) of Kalydeco (ivacaftor; Vertex) for the use in patients with cystic fibrosis (CF) ages 2 and older who have one of 23 residual function mutations.
A greater intake of bioavailable carotenoids, particularly lutein/zeaxanthin and beta-carotene, has been linked to a reduced risk of advanced age-related macular degeneration (AMD) based on two prospective cohort studies. The research appears in JAMA Ophthalmology.
Prior research has identified a connection between a genetic mutation and an increased risk of type 2 diabetes, but a new study is the first to link this genetic variation to glucose tolerance with melatonin supplementation.